METASTATIC CANCERS
Clinical trials for METASTATIC CANCERS explained in plain language.
Never miss a new study
Get alerted when new METASTATIC CANCERS trials appear
Sign up with your email to follow new studies for METASTATIC CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill tested for Tough-to-Treat cancers
Disease control Recruiting nowThis early-stage study is testing a new oral medication called REC-1245 for people with advanced cancers that have spread or cannot be removed by surgery. The main goals are to find a safe dose, see how the body processes the drug, and check for early signs that it might help shr…
Matched conditions: METASTATIC CANCERS
Phase: PHASE1, PHASE2 • Sponsor: Recursion Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Can education plus a placebo pill beat cancer fatigue?
Symptom relief Recruiting nowThis study is testing whether combining education and counseling with a placebo pill works better than education alone to reduce fatigue in people with advanced cancer. Researchers want to see if this combination improves quality of life, mood, sleep, and thinking for 240 patient…
Matched conditions: METASTATIC CANCERS
Phase: PHASE2, PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Mar 27, 2026 12:39 UTC
-
New emotional support programs tested for cancer Patients' mental health
Symptom relief Recruiting nowThis small pilot study is testing whether two different emotional support programs are practical and acceptable for people recently diagnosed with advanced cancer. The programs use techniques like cognitive behavioral therapy, hypnosis, and positive psychology to help patients be…
Matched conditions: METASTATIC CANCERS
Phase: NA • Sponsor: Université Libre de Bruxelles • Aim: Symptom relief
Last updated Mar 13, 2026 15:05 UTC
-
Decoding Cancer's DNA to find the right drug
Knowledge-focused Recruiting nowThis study aims to improve treatment for people with advanced or metastatic cancer by analyzing the unique genetic makeup of their tumor. Researchers will sequence the DNA and RNA from a patient's tumor and blood sample to identify genetic 'drivers' of the cancer. The goal is to …
Matched conditions: METASTATIC CANCERS
Phase: NA • Sponsor: British Columbia Cancer Agency • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC